# Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/retatrutide-a-gip-glp-1-and-glucagon-receptor-agonist-for-people-with-type-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Julio Rosenstock,Juan P. Frías,Ania M. Jastreboff,Yu Du,Jitong Lou,Sirel Gurbuz,Melissa K. Thomas,Mark L. Hartman,Axel Haupt,Zvonko Miličević,Tamer Coskun |
| Citations | 392 |
| DOI | 10.1016/s0140-6736(23)01053-x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4382051781 |
| PMID | 37385280 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Julio Rosenstock](https://scholariq.org/researchers/julio-rosenstock/)
- [Axel Haupt](https://scholariq.org/researchers/axel-haupt/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.